Cyclacel Pharmaceuticals ... (CYCC)
NASDAQ: CYCC
· Real-Time Price · USD
1.57
-0.18 (-10.29%)
At close: May 21, 2025, 3:59 PM
1.57
0.00%
After-hours: May 21, 2025, 07:20 PM EDT
-10.29% (1D)
| Bid | 1.57 |
| Market Cap | 34.97M |
| Revenue (ttm) | -21K |
| Net Income (ttm) | -6.31M |
| EPS (ttm) | 2.88 |
| PE Ratio (ttm) | 0.55 |
| Forward PE | -0.1 |
| Analyst | Buy |
| Ask | 1.9 |
| Volume | 276,119 |
| Avg. Volume (20D) | 183,491 |
| Open | 1.70 |
| Previous Close | 1.75 |
| Day's Range | 1.53 - 1.87 |
| 52-Week Range | 1.53 - 49.28 |
| Beta | 0.53 |
About CYCC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CYCC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CYCC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Cyclacel Pharmaceuticals has released their quartely earnings
on May 15, 2025:
2 weeks ago
+18.41%
Cyclacel Pharmaceuticals shares are trading higher...
Unlock content with
Pro Subscription
4 months ago
+24.11%
Cyclacel Pharmaceuticals shares are trading higher after the company announced a securities purchase agreement with investor David Lazar for the sale of Series C and Series D Convertible Preferred Stock for $3.1 million in gross proceeds
